Lúpus Sistémico Eritematoso

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high dose intravenous cyclophosphamide

marco.marques 2016-07-13T12:54:40+01:00 2009-1-20|Categories: Lúpus Sistémico Eritematoso|

F A Houssiau, C Vasconcelos, D D’Cruz, G D Sebastiani, E de Ramon Garrido, M G Danieli, D Abramovicz, D Blockmans, A Cauli, H Direskeneli, M Galeazzi, A Gu¨l, Y Levy, P Petera, R Popovic, R Petrovic, R A Sinico, R Cattaneo, J Font, G Depresseux, J-P Cosyns, R Cervera ABSTRACT Objective: To update the follow-up of the Euro-Lupus Nephritis Trial (ELNT), a randomised prospective trial comparing low-dose (LD) and high-dose (HD) intravenous (IV) cyclophosphamide (CY) followed by [...]

Networking in Europe for special centres of excellence for autoimmune diseases

marco.marques 2016-07-13T12:57:12+01:00 2009-1-1|Categories: Lúpus Sistémico Eritematoso|Tags: autoimmune diseases units, autoimmunologist, autoimmunology, excellence centres|

C Vasconcelos and R Cervera The studies developed by the European Working Party on Systemic Lupus Erythematosus and the European Forum on Antiphospholipid Antibodies stress the importance of the creation of international networks devoted to the study of autoimmune diseases and the need for centres of excellence in the management of these conditions. This article analyses the importance of such [...]

European consensus statement on the terminology used in the management of lupus glomerulonephritis

marco.marques 2016-07-13T12:55:31+01:00 2009-1-1|Categories: Lúpus Sistémico Eritematoso|Tags: European consensus statement, lupus nephritis, terminology|

C Gordon, D Jayne, C Pusey, D Adu, Z Amoura, M Aringer, J Ballerin, R Cervera, J Calvo-Alén, C Chizzolini, JM Dayer, A Doria, F Ferrario, J Floege, L Guillevin, M Haubitz, F Hiepe, F Houssiau, P Lesavre, L Lightstone, PL Meroni, O Meyer, B Moulin, KO’Reilly, M Praga, H Schulze-Koops, RA Sinico, KGC Smith, A Tincani, C Vasconcelos and [...]

Embarazo y enfermedades autoinmunes sistémicas

marco.marques 2016-07-13T12:58:07+01:00 2006-9-21|Categories: Lúpus Sistémico Eritematoso|

Ricard Cervera Segura, Aida Cordero Botejara, M.Rosa Oltra Sempere y M.Ángels Martínez Zamora Puntos clave La morbilidad materna y fetal puede ser grave durante una exacerbación del lupus eritematoso sistémico (LES) y el tratamiento puede estar limitado por el embarazo. No obstante, se ha demostrado en los últimos años que el embarazo en pacientes con LES no supone un riesgo alto, siempre que [...]

European Working Party on Systemic Lupus Erythematosus: A 15-year report

marco.marques 2016-07-13T13:24:43+01:00 2006-6-22|Categories: Lúpus Sistémico Eritematoso|

Ricard Cervera, Josep Font, Yehuda Shoenfeld European Working Party on Systemic Lupus Erythematosus Abstract The “European Working Party on Systemic Lupus Erythematosus” was created 15 years ago in order to promote research in Europe on the different problems related to this disease. Nowadays, more than 50 European centres are collaborating in this venture, 9 large multicentre studies are ongoing and [...]

Early Response to Immunosuppressive Therapy Predicts Good Renal Outcome in Lupus Nephritis

marco.marques 2016-07-13T13:25:36+01:00 2004-12-12|Categories: Lúpus Sistémico Eritematoso|

Lessons From Long-Term Followup of Patients in the Euro-Lupus Nephritis Trial Frédéric A. Houssiau, Carlos Vasconcelos, David D’Cruz, Gian Domenico Sebastiani, Enrique de Ramon Garrido, Maria Giovanna Danieli, Daniel Abramovicz, Daniel Blockmans, Alessandro Mathieu, Haner Direskeneli, Mauro Galeazzi, Ahmet Gül, Yair Levy, Peter Petera, Rajko Popovic, Radmila Petrovic, Renato Alberto Sinico, Roberto Cattaneo, Josep Font, Geneviéve Depresseux, Jean-Pierre Cosyns, and Ricard Cervera Objective. In the Euro-Lupus Nephritis Trial (ELNT), 90 patients with lupus nephritis were randomly assigned to a [...]